$OCEA Income Statement | Understand Stock

$OCEA

$0.00 +$0.00 (0.0%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 6 months to Dec 31, 2021
Formation and operating costs
OPERATING EXPENSES:
Research and development
General and administrative
Total operating expenses
OPERATING LOSS
OTHER INCOME (EXPENSE):
Interest income from Trust Account
Interest expense
Change in fair value of 2023 Convertible Note, SPA Warrant and the Ayrton Note Purchase Option
Loss in connection with the Share Consideration shares
Loss in connection with Backstop Put Option Liability and Fixed Maturity Consideration
Fair value of warrant issuances
Fair value of non-cash stock issuances
Transaction costs
Loss on extinguishment of debt
Loss on exchange of notes
Interest expense, including amortization of debt issuance costs
Net loss attributable to equity interest in Virion
Change in fair value of Virion Contribution Liability
Fair value of stock obligations
Other
Total other income (expense)
NET LOSS
Basic and diluted weighted average shares outstanding, Class B common stock
Common Class A
Common Class B
Class B common stock - basic and diluted net loss per share
Common Class A
Common Class B
Weighted average shares outstanding, basic
Common Class A
Common Class B
Total weighted average shares outstanding, basic
Weighted average shares outstanding, diluted
Net loss per share, basic
Common Class A
Common Class B
Total net loss per share, basic
Net loss per share, diluted

Comments